Navigation Links
NextDocs Receives $13.5 Million in Funding to Fuel Expansion
Date:9/10/2013

CONSHOHOCKEN, Pa., Sept. 10, 2013 /PRNewswire/ -- NextDocs, a leading provider of regulated content management and compliance solutions, announced today that the company has received a $13.5 million round of investments and funding commitments.  The funding round was led by OpenView Venture Partners with participation by Eastward Capital and Bridgebank Capital.

"Since its inception, NextDocs has primarily funded its operations and growth through revenue generation.  Of course, this has only been possible because of the extremely strong reception our solutions have received in the market," said Zikria Syed, Chief Executive Officer of NextDocs. "These additional equity investments and funding commitments will allow us to escalate the investment in our solutions, services and global organization – positioning the company to capture even greater market share."

A major technology platform shift in the life sciences industry is accelerating the demand for the regulated content management solutions which NextDocs sells. Nearly 37 percent of life sciences companies have reported replacing or beginning to replace their legacy document management technologies in favor of regulated content management software – and research shows that trend accelerating.

With more than 100 life sciences companies already relying on NextDocs solutions, including 5 of the top 10 pharmaceutical companies and two of the largest Clinical Research Organizations (CROs), the NextDocs platform is well on track to become the new industry standard. 

"OpenView decided to lead this second round of investment in NextDocs because we are bullish on the company," said Firas Raouf, Venture Partner at OpenView Venture Partners.  "NextDocs continues to take significant market share from the large incumbents in the market, while also expanding into adjacent and more greenfield markets.  We see NextDocs growing aggressively and becoming a much larger company over the next few years."

NextDocs is already an Inc. 500 and Deloitte Fast 50 company.  OpenView Venture Partners is the company's largest investor and also its first institutional investor, having provided a $10 million Series A round of investment in 2011.   

Last month, NextDocs announced the appointment of William Levering as Chief Financial Officer and the appointment of Robert Steinkrauss and George Riedel as members of its board of directors. Levering brings more than 30 years of financial management experience to NextDocs, including more than a dozen years' experience as a CFO at both public and private technology companies. 

About NextDocs Corporation

NextDocs is the global leader in providing compliance software solutions including quality management software, regulatory document management, and clinical portals. NextDocs solutions enable businesses in regulated industries to achieve compliance with FDA and other regulations while automating processes, improving efficiency, and dramatically reducing costs. NextDocs' customers include pharmaceutical companies, biotechs, medical device companies, and CROs. For more information on NextDocs Corporation and its software solutions, visit www.nextdocs.com.

About OpenView Venture Partners

OpenView Venture Partners (www.openviewpartners.com) is an expansion-stage venture capital fund based in Boston that is focused on high-growth software, Internet, and technology-enabled companies. Through its staff of seasoned operating executives, who collectively bring several decades of technology and management experience to the firm, OpenView is able to help portfolio companies quickly optimize their product, go-to-market, and organizational and operational functions. Founded in 2006, the firm invests globally and has approximately $445 million in total capital under management.

Contact:
Dan Cahill
1-917-617-0106
dcahill@roaringpr.com


'/>"/>
SOURCE NextDocs Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NextDocs and Novella to Present on eTMF at DIA 2013
2. NextDocs Expands Customer Roster by More Than 10 Percent
3. NextDocs Launches QuickStart for Emerging Growth Companies
4. NextDocs 6: The New Enterprise Standard for Regulated Content Management
5. NextDocs Corporation Announces Trial Exchange, a Clinical Portal Designed Specifically for Clinical Trial Sites and Integrated with eTMF
6. TWi Biotechnology Receives Patent Allowance for Its Lead Drug Candidate AC-201 in the United States
7. Unique New PIR Knee System Receives CE Mark
8. EECP Therapy Receives Class lla Recommendation in European Society of Cardiology Guidelines for the Management of Stable Coronary Artery Disease
9. Mylan Acquisition of Agila Receives Approval from Indias Foreign Investment Promotion Board and Cabinet Committee on Economic Affairs
10. Halozyme Announces Roche Receives Marketing Authorization for Herceptin SC in European Union
11. HeartWare Receives FDA Approval To Enroll Supplemental Patient Cohort In Destination Therapy Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... February 12, 2016 ... vermerkt)   http://www.sedar.com ) und ... abrufbar.    --> http://www.sedar.com ... http://www.telestatherapeutics.com abrufbar.    --> ... heute seinen Konzernabschluss des zweiten Quartals ...
(Date:2/12/2016)...  Memorial Hermann Health System has teamed up with ... bring a one-of-a-kind experience to pediatric patients at ... as 360-degree video and Google Cardboard, Howard was able ... giving the patients and their families an unexpected, and ... on video . Memorial Hermann IRONMAN ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... , ... Valentine’s Day is nearly upon us, and most singles could probably ... flawless hair, and a sparkling personality are all well and good, but if somebody ... home with Rover. (Actually, man’s best friend might not even want to be near ...
(Date:2/13/2016)... ... February 13, 2016 , ... In its newly ... vein visualization technology should be used to ensure patient safety when placing an ... INS Standards mandate the use of vein visualization technology in patients with difficult ...
(Date:2/12/2016)... ... 12, 2016 , ... According to an article published February 4th ... significant portion of hernia repairs throughout the United States. Commenting on this article, Beverly ... that this trend has not only been expected, but it seems to be a ...
(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , ... , As Winston Churchill said, “Those who don’t learn from history are doomed to ... expect when they come knocking this year. But that takes time. , Take a ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., a ... closed for the ISE Southeast Awards 2016. Finalists and winners of the ISE® ... Southeast Executive Forum and Awards Gala on March 15, 2016 at the Westin ...
Breaking Medicine News(10 mins):